Composition, form of production and packaging
? Tablets for resorption (lemon, pineapple, orange).
1 tab.
amylmethacresol 600 Ојg
2,4-dichlorobenzyl alcohol 1.2 mg
6 pcs. - Strips (2) - packs of cardboard.
6 pcs. - Strips (4) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2014.
PHARMACHOLOGIC EFFECT
Combined antiseptic preparation for topical application in the oral cavity and pharynx. Has antimicrobial effect. It is active against gram-positive and gram-negative microorganisms.
PHARMACOKINETICS
Due to low systemic absorption, there is no data on the pharmacokinetics of the drug Ajicept.
INDICATIONS
- Infectious and inflammatory diseases of the oral cavity and pharynx.
DOSING MODE
For resorption in the oral cavity. Adults take 1 tablet every 2 hours. The maximum daily dose is 8 tablets. Children older than 5 years are prescribed 1 tablet every 4 hours. Tablets dissolve until complete dissolution.
SIDE EFFECT
When used according to the indications in recommended doses, the side effect of the drug was not noted.
CONTRAINDICATIONS
- Children's age till 5 years;
- Hypersensitivity to the components of the drug.
APPLICATION FOR CHILDREN
Contraindication: children under 5 years
SPECIAL INSTRUCTIONS
When taking Adzisept, patients with diabetes should take into account the sugar content in each tablet: Adzysept tablets for classic resorption - 2.4 g of sucrose, Agicept tablets for resorption of honey-lemon - 840 mg of dextrose and 1.56 g of sucrose; Adizept tablets for resorption menthol-eucalyptus - 840 mg of dextrose and 1.56 g of sucrose.
DRUG INTERACTION
Clinically significant interaction of the drug Adjicept with drugs of other groups was not revealed.
TERMS OF RELEASE FROM PHARMACY
Without recipe.
TERMS AND CONDITIONS OF STORAGE
In a dry, the dark place at a temperature of no higher than 25 В° C. Keep out of the reach of children. Shelf life - 3 years.
